6xFU/Epirubicin/Cyclophosphamide (FEC) Compared to 3xFEC-3xDocetaxel in High-risk Node-negative Breast Cancer Patients
Clinical trial NCT01222052 · UNKNOWN
Trial details
- NCT number
- NCT01222052
- Sponsor
- Martin-Luther-Universität Halle-Wittenberg
- Status
- UNKNOWN
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2002-01-01
- Primary completion
- 2009-02-01
- Enrollment
- 4150
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.